BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 29748564)

  • 1. Screening for dysplasia with Lugol chromoendoscopy in longstanding idiopathic achalasia.
    Ponds FA; Moonen A; Smout AJPM; Rohof WOA; Tack J; van Gool S; Bisschops R; Bredenoord AJ; Boeckxstaens GE
    Am J Gastroenterol; 2018 Jun; 113(6):855-862. PubMed ID: 29748564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lugol chromoendoscopy combined with brush cytology in patients at risk for esophageal squamous cell carcinoma.
    Boller D; Spieler P; Schoenegg R; Neuweiler J; Kradolfer D; Studer R; Grossenbacher R; Zuercher U; Meyenberger C; Borovicka J
    Surg Endosc; 2009 Dec; 23(12):2748-54. PubMed ID: 19444514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 French endoscopy centers.
    Dubuc J; Legoux J-; Winnock M; Seyrig J-; Barbier J-; Barrioz T; Laugier R; Boulay G; Grasset D; Sautereau D; Grigoresco D; Butel J; Scoazec J-; Ponchon T;
    Endoscopy; 2006 Jul; 38(7):690-5. PubMed ID: 16874909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-procedure oral administration of pronase improves efficacy of lugol chromoendoscopy in esophageal squamous cell carcinoma screening: a prospective, double-blinded, randomized, controlled trial.
    Zhao X; Guo M; Zhu S; Zhang L; Dong T; Luo H; Yu W; Zhu J; Fan X; Han Y; Liu Z
    Surg Endosc; 2023 Jun; 37(6):4421-4430. PubMed ID: 36781469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fujinon intelligent color enhancement for the diagnosis of early esophageal squamous cell carcinoma and precancerous lesion.
    Li YX; Shen L; Yu HG; Luo HS; Yu JP
    Turk J Gastroenterol; 2014 Aug; 25(4):365-9. PubMed ID: 25254516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Narrow-band imaging vs Lugol chromoendoscopy in screening for esophageal squamous cell neoplasia: a randomized trial.
    Chaber-Ciopinska A; Kiprian D; Wieszczy P; Bielasik A; Bugajski M; Januszewicz W; Jarzabski A; Niemiec M; Mroz A; Kawecki A; Regula J; Kaminski MF
    Pol Arch Intern Med; 2023 Oct; 133(10):. PubMed ID: 36916462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Narrow-band imaging versus Lugol chromoendoscopy for esophageal squamous cell cancer screening in normal endoscopic practice: randomized controlled trial.
    Gruner M; Denis A; Masliah C; Amil M; Metivier-Cesbron E; Luet D; Kaasis M; Coron E; Le Rhun M; Lecleire S; Antonietti M; Legoux JL; Lefrou L; Renkes P; Tarreirias AL; Balian P; Rey P; Prost B; Cellier C; Rahmi G; Samaha E; Fratte S; Guerrier B; Landel V; Touzet S; Ponchon T; Pioche M
    Endoscopy; 2021 Jul; 53(7):674-682. PubMed ID: 32698233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult dysplasia is disclosed by Lugol chromoendoscopy in alcoholics at high risk for squamous cell carcinoma of the esophagus.
    Fagundes RB; de Barros SG; Pütten AC; Mello ES; Wagner M; Bassi LA; Bombassaro MA; Gobbi D; Souto EB
    Endoscopy; 1999 May; 31(4):281-5. PubMed ID: 10376452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does daily alcohol and/or cigarette consumption cause low-grade dysplasia, a precursor of esophageal squamous cell carcinoma?
    Kaneko K; Murakami Y; Katagiri A; Konishi K; Kubota Y; Muramoto T; Kushima M; Ohtsu A; Imawari M
    J Clin Gastroenterol; 2010 Mar; 44(3):173-9. PubMed ID: 19826274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer.
    Muto M; Hironaka S; Nakane M; Boku N; Ohtsu A; Yoshida S
    Gastrointest Endosc; 2002 Oct; 56(4):517-21. PubMed ID: 12297767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating synchronous esophageal cancer in head and neck cancer patients using Lugol dye chromoendoscopy.
    Laohawiriyakamol S; Sunpaweravong S; Leelamanit V; Pruegsanusak K; Sinkijcharoenchai W
    J Med Assoc Thai; 2014 Nov; 97(11):1164-70. PubMed ID: 25675681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lugol Chromoendoscopy Detects Esophageal Dysplasia With Low Levels of Sensitivity in a High-Risk Region of China.
    Li J; Xu R; Liu M; Cai H; Cao C; Liu F; Li F; Guo C; Pan Y; He Z; Ke Y
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1585-1592. PubMed ID: 29174712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lugol chromo-endoscopy versus narrow band imaging for endoscopic screening of esophageal squamous-cell carcinoma in patients with a history of cured esophageal cancer: a feasibility study.
    Lecleire S; Antonietti M; Iwanicki-Caron I; Duclos A; Lemoine F; Pessot FL; Michel P; Ducrotté P; Di Fiore F
    Dis Esophagus; 2011 Aug; 24(6):418-22. PubMed ID: 21309914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esophageal Squamous Dysplasia is Common in Asymptomatic Kenyans: A Prospective, Community-Based, Cross-Sectional Study.
    Mwachiro MM; Burgert SL; Lando J; Chepkwony R; Bett C; Bosire C; Abnet CC; Githanga J; Waweru W; Giffen CA; Murphy G; White RE; Topazian MD; Dawsey SM
    Am J Gastroenterol; 2016 Apr; 111(4):500-7. PubMed ID: 26902228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of esophageal squamous cell carcinoma in patients with squamous dysplasia: a nationwide cohort study in the Netherlands.
    van Tilburg L; Spaander MCW; Bruno MJ; Oudijk L; Heij LR; Doukas M; Koch AD
    Dis Esophagus; 2023 Nov; 36(12):. PubMed ID: 37480179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lugol chromoendoscopic screening for esophageal dysplasia/early squamous cell carcinoma in patients with esophageal symptoms in low-risk region in China.
    Shao Y; Yu ZL; Ji M; Wu YD; Yu YZ; Liang XM; Yu LI; Niu YL; Li P; Zhang ST
    Oncol Lett; 2015 Jul; 10(1):45-50. PubMed ID: 26170975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Narrow band imaging versus lugol chromoendoscopy to diagnose squamous cell carcinoma of the esophagus: a systematic review and meta-analysis.
    Morita FH; Bernardo WM; Ide E; Rocha RS; Aquino JC; Minata MK; Yamazaki K; Marques SB; Sakai P; de Moura EG
    BMC Cancer; 2017 Jan; 17(1):54. PubMed ID: 28086818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of Iodine Staining Associates With Progression of Esophageal Lesions in a Prospective Endoscopic Surveillance Study in China.
    Liu M; Liu Z; Liu F; Guo C; Xu R; Li F; Liu A; Yang H; Zhang S; Shen L; Duan L; Wu Q; Cao C; Pan Y; Liu Y; Li J; Cai H; He Z; Ke Y
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1626-1635.e7. PubMed ID: 31518715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristic of esophageal cancer without lugol-voiding lesions in the background esophagus.
    Kuwabara H; Chiba H; Tachikawa J; Okada N; Ashikari K; Arimoto J; Nakaoka M; Sakai E; Goto T; Ohata K
    Dig Endosc; 2020 May; 32(4):621-627. PubMed ID: 31965622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic findings corresponding to multiple Lugol-voiding lesions in the esophageal background mucosa.
    Matsuno K; Ishihara R; Nakagawa K; Ohmori M; Iwagami H; Inoue S; Iwatsubo T; Nakahira H; Matsuura N; Shichijyo S; Maekawa A; Takashi K; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Matsunaga T
    J Gastroenterol Hepatol; 2019 Feb; 34(2):390-396. PubMed ID: 30101499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.